# OnCo record tae-life-sciences (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/tae-life-sciences/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "tae-life-sciences" ;
  schema:name "TAE Life Sciences"@en ;
  schema:description "TAE Life Sciences is developing boron neutron capture therapy, in which a boron drug collects in cancer cells and a hospital-based neutron beam then triggers a tiny nuclear reaction inside those cells to destroy them while sparing nearby healthy tissue."@en ;
  schema:url <https://onco.cc/companies/tae-life-sciences/>, <https://taelifesciences.com> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://taelifesciences.com>, <https://taelifesciences.com/wp-content/uploads/2026/02/TAE-Life-Sciences-to-Develop-Groundbreaking-Therapy.pdf>, <https://cen.acs.org/articles/96/i12/40-million-boron-neutron-capture.html>, <https://taelifesciences.com/company/news/> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/glioblastoma/> ;
  onco:sections <https://onco.cc/fronts/radiation/>, <https://onco.cc/fronts/devices/> ;
  onco:technologies <https://onco.cc/technologies/bnct/> .